Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)

Dutch Initiative on Crohn and Colitis

Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)

Dutch Initiative on Crohn and Colitis

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S66-S67
Aantal pagina's	2
Tijdschrift	Journal of Crohn's and Colitis
Volume	12
Status	Published - feb.-2018

Toegang tot document

https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/dop052-vedolizumab-vs-ustekinumab-for-crohn-x2019-s-disease-comparative-effectiveness-in-a-real-life-observational-cohort-study-icc-case-series.html

Handle.net

Permanente koppeling

Citeer dit

Dutch Initiative on Crohn and Colitis (2018). Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series). Journal of Crohn's and Colitis, 12, S66-S67. https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/dop052-vedolizumab-vs-ustekinumab-for-crohn-x2019-s-disease-comparative-effectiveness-in-a-real-life-observational-cohort-study-icc-case-series.html

@article{7afeec6d5d9049899e6949a992f8de7c,

title = "Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)",

author = "{Dutch Initiative on Crohn and Colitis} and V. Biemans and {van der Woude}, C. and {van der Meulen-de Jong}, A. and G. Dijkstra and {de Boer}, N. and B. Oldenburg and C. Ponsioen and {de Vries}, A. and D. Wintjens and F. Hoentjen and M. Pierik",

year = "2018",

month = feb,

language = "English",

volume = "12",

pages = "S66--S67",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

Dutch Initiative on Crohn and Colitis 2018, 'Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)', Journal of Crohn's and Colitis, vol. 12, blz. S66-S67. <https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/dop052-vedolizumab-vs-ustekinumab-for-crohn-x2019-s-disease-comparative-effectiveness-in-a-real-life-observational-cohort-study-icc-case-series.html>

TY - JOUR

T1 - Vedolizumab vs. ustekinumab for Crohn's disease

T2 - comparative effectiveness in a real-life observational cohort study (ICC case series)

AU - Dutch Initiative on Crohn and Colitis

AU - Biemans, V.

AU - van der Woude, C.

AU - van der Meulen-de Jong, A.

AU - Dijkstra, G.

AU - de Boer, N.

AU - Oldenburg, B.

AU - Ponsioen, C.

AU - de Vries, A.

AU - Wintjens, D.

AU - Hoentjen, F.

AU - Pierik, M.

PY - 2018/2

Y1 - 2018/2

M3 - Meeting Abstract

SN - 1873-9946

VL - 12

SP - S66-S67

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -